MarketCapTrends
VKTX
Viking Therapeutics Inc. (VKTX)
NASDAQ · Healthcare

Viking Therapeutics Inc. Cash on Hand 2014–2025

Viking Therapeutics Inc. annual/quarterly cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Viking Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 165.8M, a 521.57% increase year-over-year.
  • Viking Therapeutics Inc. cash on hand for 2025 were 165.8M, a 521.57% increase from 2024.
  • Viking Therapeutics Inc. cash on hand for 2024 were 26.7M, a 51.95% decrease from 2023.
  • Viking Therapeutics Inc. cash on hand for 2023 were 55.5M, a 51.55% increase from 2022.
  • Viking Therapeutics Inc. cash on hand for 2022 were 36.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Viking Therapeutics Inc. Annual Cash on Hand (Millions of US $)
2025$166
2024$27
2023$56
2022$37
2021$26
2020$29
2019$8
2018$25
2017$9
2016$3
2015$1
2014$1
Viking Therapeutics Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$166
2024-12-31$27
2023-12-31$56
2022-12-31$37
2021-12-31$26
2020-12-31$29
2019-12-31$8
2018-12-31$25
2017-12-31$9
2016-12-31$3
2015-12-31$1
2014-12-31$1

Viking Therapeutics Inc. Cash on Hand — FAQ

Viking Therapeutics Inc. (VKTX) cash on hand over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VKTX's cash on hand history?

The chart and table above show Viking Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.